Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Exome Sequencing May Enable Prenatal Diagnosis, Management
...
Already a member? Log in here
Utility of Post Op Lab Testing Questioned for Some Gynecologic Patients
...
Already a member? Log in here
Genetic Predisposition to Stress Fractures ID’d in Healthy Individuals
...
Already a member? Log in here
Prospective Trial Shows Utility of Liquid Biopsy for Lung Cancer
...
Already a member? Log in here
Low Histopathologic Agreement for DCIS, Atypia Breast Cancer
...
Already a member? Log in here
Molecular Profiling of Lung Cancer Tumors Feasible on National Scale
From - Diagnostic Testing & Emerging Technologies
Routine, nationwide molecular profiling of patients with advanced non-small cell lung cancer (NSCLC) is feasible and the screening detects actionable alterations that…
Viewpoints Debate Merits of Universal Tumor Sequencing
From - Diagnostic Testing & Emerging Technologies
There is universal recognition that genomic information has forever changed oncology care and is increasingly driving treatment decisions. For patients who have exhausted standard therapy or with…
At-Home Testing Company Cor Crowdfunding for Commercialization
From - Diagnostic Testing & Emerging Technologies
At-home testing company Cor (San Francisco) has taken to online crowdfunding to commercialize its blood chemistry device. As of April 6, the company had pledges on…
